Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Rheumatoid Arthritis

Free Subscription 13.02.2023 1 Ann Rheum Dis 1 Arthritis Res Ther 1 Clin Rheumatol 1 Curr Opin Rheumatol 2 J Rheumatol 3 Rheumatol Int 1 Scand J Rheumatol 1 Z Rheumatol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Rheum Dis

1. O'NEIL LJ, Oliveira CB, Wang X, Navarrete M, et al
   Neutrophil extracellular trap-associated carbamylation and histones trigger osteoclast formation in rheumatoid arthritis.
   Ann Rheum Dis. 2023 Feb 3:ard-2022-223568. doi: 10.1136/ard-2022-223568.
   PubMed         Abstract available
   
   

   
   Arthritis Res Ther

2. KENNEY HM, Wood RW, Ramirez G, Bell RD, et al
   Implementation of automated behavior metrics to evaluate voluntary wheel running effects on inflammatory-erosive arthritis and interstitial lung disease in TNF-Tg mice.
   Arthritis Res Ther. 2023;25:17.
   PubMed         Abstract available
   
   

   
   Clin Rheumatol

3. ROGHANI SA, Lotfi R, Soleymani B, Samimi Z, et al
   Investigating the correlation of the NF-kappaB and FoxP3 gene expression with the plasma levels of pro- and anti-inflammatory cytokines in rheumatoid arthritis patients.
   Clin Rheumatol. 2023 Feb 4. doi: 10.1007/s10067-023-06521.
   PubMed         Abstract available
   
   

   
   Curr Opin Rheumatol

4. ZACCARDELLI A, Wallace ZS, Sparks JA
   Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic.
   Curr Opin Rheumatol. 2023 Feb 8. doi: 10.1097/BOR.0000000000000930.
   PubMed         Abstract available
   
   

   
   J Rheumatol

5. ITO Y, Nakahara H, Nakajima A
   Development of Pulmonary Alveolar Proteinosis in a Patient With Adult-Onset Still Disease Treated With Tocilizumab.
   J Rheumatol. 2023;50:288-289.
   PubMed        
   
   
6. WENG J, Zhou LL, Hahn T, Shojania K, et al
   Adult-Onset Still Disease After ChAdOx1 nCOV-19 Vaccination.
   J Rheumatol. 2023;50:290-291.
   PubMed        
   
   

   
   Rheumatol Int

7. KOSTER F, Bakx PLH, Kok MR, Barreto DL, et al
   Multimorbidity status and annual healthcare expenditures of rheumatoid arthritis patients: a Dutch hospital-centered versus population-based comparison.
   Rheumatol Int. 2023 Feb 10. doi: 10.1007/s00296-023-05282.
   PubMed         Abstract available
   
   
8. PARASCHOU V, Partalidou S, Siolos P, Papadopoulou Z, et al
   Prevalence of hearing loss in patients with Sjogren syndrome: a systematic review and meta-analysis.
   Rheumatol Int. 2023;43:233-244.
   PubMed         Abstract available
   
   
9. YOLCU G, Abacar KY, Kenis-Coskun O, Nevsun-Inanc G, et al
   Comparison of cutaneous silent period parameters in patients with primary Sjogren's syndrome with the healthy population and determination of its relationship with clinical parameters.
   Rheumatol Int. 2023;43:355-362.
   PubMed         Abstract available
   
   

   
   Scand J Rheumatol

10. LANDGREN AJ, Klingberg E, Jacobsson L, Bergsten U, et al
    Health-related quality of life in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis, results from a cross-sectional survey in Western Sweden.
    Scand J Rheumatol. 2023 Feb 6:1-13. doi: 10.1080/03009742.2022.2157962.
    PubMed         Abstract available
    
    

    
    Z Rheumatol

11. FIEHN C, Zinke S, Haas JS, Meise D, et al
    Real-world treatment persistence in patients with rheumatoid arthritis initiating DMARDs in Germany-a health insurance claims data analysis.
    Z Rheumatol. 2023 Feb 9. doi: 10.1007/s00393-023-01323.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: